IXJ holdings and overlap
iShares Global Healthcare ETF (IXJ) holds 109 positions in its iShares file of 2026-10-27. Its three largest are Eli Lilly (LLY) at 10.85%, Johnson & Johnson (JNJ) at 6.85% and AbbVie (ABBV) at 5.35%, and its ten largest make up 47.5% of the fund.
In its iShares file of 2026-10-27, IXJ is 99.7% health care by sector, with none of it in mega-cap tech or in the ten largest US companies by market value. By country, 73.1% of IXJ is in the United States, 9.8% in Switzerland, 4.9% in the United Kingdom and 3.6% in Japan.
What does IXJ hold, as of its issuer file of 2026-10-27?
IXJ spreads its weight across 109 positions, against a median of 61 across the 28 Health Care funds with a page here. The position IXJ carries furthest above that group is Johnson & Johnson at 6.85% of the fund, a company the median fund in that group does not hold at all.
| Rank | Company | Weight | Weight bar |
|---|---|---|---|
| 1 | LLY Eli Lilly | 10.85% | |
| 2 | JNJ Johnson & Johnson | 6.85% | |
| 3 | ABBV AbbVie | 5.35% | |
| 4 | UNH UnitedHealth Group | 4.28% | |
| 5 | MRK Merck | 4.06% | |
| 6 | ROP.CH Roche PS Par AG | 3.93% | |
| 7 | NOVN.CH Novartis AG | 3.31% | |
| 8 | AZN.GB Astrazeneca PLC | 3.08% | |
| 9 | TMO Thermo Fisher Scientific | 2.98% | |
| 10 | AMGN Amgen | 2.82% | |
| 11 | GILD Gilead Sciences | 2.29% | |
| 12 | ABT Abbott Laboratories | 2.07% | |
| 13 | PFE Pfizer | 1.98% | |
| 14 | ISRG Intuitive Surgical | 1.83% | |
| 15 | DHR Danaher | 1.69% | |
| 16 | VRTX Vertex Pharmaceuticals | 1.53% | |
| 17 | BMY Bristol Myers Squibb | 1.46% | |
| 18 | NOVOB.DK Novo Nordisk | 1.43% | |
| 19 | CVS CVS Health | 1.36% | |
| 20 | MDT Medtronic | 1.34% | |
| 21 | MCK McKesson | 1.31% | |
| 22 | SYK Stryker | 1.22% | |
| 23 | GSK.GB Glaxosmithkline | 1.2% | |
| 24 | ELV Elevance Health | 1.06% | |
| 25 | SAN.FR Sanofi SA | 1.05% | |
| 26 | REGN Regeneron Pharmaceuticals | 0.93% | |
| 27 | CI Cigna | 0.92% | |
| 28 | MRNA Moderna | 0.9% | |
| 29 | CSL.AU CSL | 0.77% | |
| 30 | HCA HCA Healthcare | 0.77% | |
| 31 | BSX Boston Scientific | 0.76% | |
| 32 | 4502.JP Takeda Pharmaceutical | 0.76% | |
| 33 | COR Cencora | 0.72% | |
| 34 | EL.FR Essilorluxottica SA | 0.69% | |
| 35 | CAH Cardinal Health | 0.67% | |
| 36 | 7741.JP Hoya | 0.65% | |
| 37 | ARGX.BE Argenx | 0.64% | |
| 38 | LONN.CH Lonza Group AG | 0.63% | |
| 39 | BDX Becton Dickinson | 0.62% | |
| 40 | EW Edwards Lifesciences | 0.61% | |
| 41 | BAYN.DE Bayer AG | 0.59% | |
| 42 | A Agilent Technologies | 0.58% | |
| 43 | HUM Humana | 0.58% | |
| 44 | VEEV Veeva Systems | 0.54% | |
| 45 | WAT Waters | 0.53% | |
| 46 | IQV IQVIA | 0.52% | |
| 47 | IDXX Idexx Laboratories | 0.51% | |
| 48 | HLN.GB Haleon PLC | 0.51% | |
| 49 | SDZ.CH Sandoz Group AG | 0.51% | |
| 50 | ILMN Illumina | 0.49% | |
| 51 | GALD.CH Galderma Group N AG | 0.48% | |
| 52 | BIIB Biogen | 0.44% | |
| 53 | 4578.JP Otsuka Holdings | 0.42% | |
| 54 | RMD ResMed | 0.42% | |
| 55 | UCB.BE Ucb SA | 0.42% | |
| 56 | ALC.CH Alcon AG | 0.4% | |
| 57 | CNC Centene | 0.4% | |
| 58 | MTD Mettler Toledo | 0.39% | |
| 59 | ZTS Zoetis | 0.38% | |
| 60 | GEHC GE HealthCare | 0.37% | |
| 61 | 4568.JP Daiichi Sankyo Ltd | 0.36% | |
| 62 | DXCM Dexcom | 0.34% | |
| 63 | 4503.JP Astellas Pharma | 0.34% | |
| 64 | WST West Pharmaceutical Services | 0.33% | |
| 65 | GMAB.DK Genmab | 0.32% | |
| 66 | 4519.JP Chugai Pharmaceutical Ltd | 0.31% | |
| 67 | 6160.HK Beone Medicines AG | 0.31% | |
| 68 | LH Labcorp | 0.31% | |
| 69 | DGX Quest Diagnostics | 0.31% | |
| 70 | 4543.JP Terumo | 0.26% | |
| 71 | STE Steris | 0.26% | |
| 72 | VTRS Viatris | 0.25% | |
| 73 | FRE.DE Fresenius N | 0.25% | |
| 74 | MRK.DE Merck | 0.24% | |
| 75 | PHIA.NL Koninklijke Philips | 0.24% | |
| 76 | INCY Incyte | 0.23% | |
| 77 | ZBH Zimmer Biomet | 0.21% | |
| 78 | RVTY Revvity | 0.21% | |
| 79 | CRL Charles River Laboratories | 0.2% | |
| 80 | SHL.DE Siemens Healthineers AG | 0.19% | |
| 81 | SOON.CH Sonova Holding AG | 0.19% | |
| 82 | 4507.JP Shionogi | 0.18% | |
| 83 | RO.CH Roche Holding AG | 0.16% | |
| 84 | STMN.CH Straumann Holding AG | 0.16% | |
| 85 | BAX Baxter International | 0.15% | |
| 86 | SN.GB Smith and Nephew PLC | 0.15% | |
| 87 | 7733.JP Olympus | 0.14% | |
| 88 | SOLV Solventum | 0.14% | |
| 89 | COO Cooper Companies | 0.14% | |
| 90 | TECH Bio-Techne | 0.13% | |
| 91 | SIG.AU Sigma Healthcare | 0.13% | |
| 92 | QIA.DE Qiagen | 0.12% | |
| 93 | ERF.FR Eurofins Scientific | 0.12% | |
| 94 | PODD Insulet | 0.12% | |
| 95 | ALGN Align Technology | 0.12% | |
| 96 | 4523.JP Eisai | 0.11% | |
| 97 | UHS Universal Health Services | 0.11% | |
| 98 | COLOB.DK Coloplast B | 0.1% | |
| 99 | FME.DE Fresenius Medical Care AG | 0.1% | |
| 100 | SRT3.DE Sartorius Pref AG | 0.1% |
The most recent file iShares has published for IXJ is dated 2026-10-27, 1 day before these prices, which is the median for the iShares ETFs covered here. Every one of the 109 positions IXJ holds, with its weight, is in the fund's JSON file. See the other 118 ETFs with a page here that hold LLY, and how their weights compare with the 10.85% IXJ gives it.
Category: Health Care, set by TickerInside from the ETF's own latest file. In its file of 2026-10-27, 100% of its stocks whose sector is known are health care companies, each in the sector the site gives that company. How categories are set.
https://tickerinside.com/api/v1/fund/ixj.jsonhttps://tickerinside.com/api/v1/fund/ixj.csv=IMPORTDATA("https://tickerinside.com/api/v1/fund/ixj.csv")If your sheet uses a decimal comma: =IMPORTDATA("https://tickerinside.com/api/v1/fund/ixj.csv"; ","; "en_US")curl -s https://tickerinside.com/api/v1/fund/ixj.jsonHow much money went into or out of IXJ?
On the close of Friday, October 23, 2026, IXJ neither created nor redeemed shares. Over its last 5 closes, a net outflow of $103 million.
From IXJ's own holdings files. Every ETF's latest flows.
How is IXJ split by sector and country?
| Sector | Weight | Weight bar |
|---|---|---|
| Health care | 99.7% |
| Country | Weight | Weight bar |
|---|---|---|
| United States | 73.1% | |
| Switzerland | 9.8% | |
| United Kingdom | 4.9% | |
| Japan | 3.6% | |
| France | 1.9% | |
| Denmark | 1.9% | |
| Germany | 1.6% | |
| Belgium | 1.1% | |
| Australia | 1.1% | |
| China | 0.3% | |
| Other countries | 0.4% |
From its iShares file of 2026-10-27. How these are measured.
What did IXJ hold in its SEC reports since 2019?
In IXJ's SEC filings, its largest position went from Johnson & Johnson (JNJ) at 6.86% on 2019-09-30 to Lilly (Eli) (LLY) at 10.93% on 2026-06-30, across 28 quarterly reports.
| Report | Positions | Largest | Top 10 |
|---|---|---|---|
| 2019-09-30 | 102 | JNJ 6.86% | 38.5% |
| 2019-12-31 | 101 | JNJ 6.86% | 39.0% |
| 2020-12-31 | 110 | JNJ 6.58% | 37.5% |
| 2021-12-31 | 117 | UNH 6.25% | 38.8% |
| 2022-12-31 | 112 | UNH 7.02% | 42.2% |
| 2023-12-31 | 113 | UNH 6.84% | 42.8% |
| 2024-12-31 | 111 | LLY 8.73% | 43.6% |
| 2025-12-31 | 114 | LLY 10.78% | 45.4% |
| 2026-06-30 | 110 | LLY 10.93% | 47.8% |
The first report, then the last of each year, of the 28 reports IXJ filed on SEC Form N-PORT from 2019-09-30 to 2026-06-30, each company under its ticker today. Every position of every report is in its quarterly file, and at any date at /api/v1/history/ixj/{date}.json. How these are read.
What does IXJ duplicate?
The ETF nearest to IXJ is XLV: the two hold 73.1% of their weight in common, in the 60 companies both own, and 73.4% of IXJ itself is also held there. Owning IXJ alongside the ETFs at the top of this table means holding mostly the same companies twice.
| ETF | Overlap by weight | Of IXJ held there | Of that ETF in IXJ | Companies in both | Overlap bar |
|---|---|---|---|---|---|
| XLV | 73.1% | 73.4% | 100.0% | 60 | |
| VHT | 72.1% | 73.4% | 86.0% | 60 | |
| IYH | 68.7% | 68.9% | 91.4% | 56 | |
| RSPH | 46.0% | 73.4% | 100.0% | 60 | |
| BMED | 35.2% | 47.4% | 76.8% | 27 | |
| PJP | 32.7% | 39.5% | 57.3% | 12 | |
| PPH | 29.9% | 33.3% | 58.9% | 10 | |
| XT | 26.1% | 60.9% | 26.2% | 29 | |
| IHE | 25.8% | 25.9% | 70.3% | 7 | |
| CANC | 22.8% | 38.4% | 26.0% | 10 | |
| PFM | 17.6% | 53.1% | 17.6% | 24 | |
| VIG | 17.6% | 49.7% | 17.7% | 22 |
The holdings of VHT and CANC are from their SEC Form N-PORT filings for the period ended 2026-05-31, filed 2026-07-29. PPH's holdings are from its SEC Form N-PORT for the period ended 2026-06-30, filed 2026-08-26. VIG's holdings are from its SEC Form N-PORT for the period ended 2026-07-31, filed 2026-09-28. The other ETFs' holdings are from their issuers' latest files. Check IXJ against any ETF in the ETF overlap calculator · how overlap is measured.
What adds something different to IXJ?
SOXX shares 0% of weight with IXJ and its weekly returns correlate with it at 0.13 over three years. The table lists the covered ETFs with the least in common with IXJ, least shared weight first and, among equals, lowest correlation.
| ETF | Name | Overlap by weight | Correlation, 3y | Companies in both |
|---|---|---|---|---|
| SOXX | iShares Semiconductor ETF | 0.0% | 0.13 | 0 |
| PFF | iShares Preferred and Income Securities ETF | 0.0% | 0.26 | 0 |
| RING | iShares MSCI Global Gold Miners ETF | 0.0% | 0.31 | 0 |
| XSMO | Invesco S&P SmallCap Momentum ETF | 0.0% | 0.35 | 0 |
| PICK | iShares MSCI Global Metals & Mining Producers ETF | 0.0% | 0.39 | 0 |
| IJR | iShares Core S&P Small-Cap ETF | 0.0% | 0.47 | 0 |
| IJH | iShares Core S&P Mid-Cap ETF | 0.0% | 0.48 | 0 |
| USRT | iShares Core U.S. REIT ETF | 0.0% | 0.54 | 0 |
Cost, returns and risk
| Expense ratio | 0.38% |
|---|---|
| Dividend yield | 1.41% |
| Total return, 1 year | 21.8% |
| Total return, 3 years cumulative | 40.8% |
| Total return, 5 years cumulative | 34.2% |
| Volatility, annualised | 14.9% |
| Worst fall, 3 years | -16.4% |
| Beta against SPY, 3 years of weekly returns | 0.42 |
| Weight in the ten largest positions | 47.5% |
| Largest single position | 10.8% |
| Assets under management | $4.3B |
Expense ratio, yield and assets are reference data (the expense ratio from IXJ's SEC filing of 2026-07-27); the weight in the ten largest positions and the largest single position are from the issuer file of 2026-10-27; every other figure is computed here from weekly closes.
How it moves with the market
| Against | Correlation, 3 years | Covariance, annualised, in percent squared |
|---|---|---|
| SPY | 0.39barely linked | 80 |
| QQQ | 0.21barely linked | 59 |
Weekly total returns. What the bands mean · why the covariance is printed.
Year by year
| Year | Total return |
|---|---|
| 2026 | 13.3% |
| 2025 | 15.0% |
| 2024 | 0.6% |
| 2023 | 3.6% |
| 2022 | -4.9% |
One year
Where to go next
- IYH, iShares U.S. Healthcare ETF
- PBE, Invesco Biotechnology & Genome ETF
- PJP, Invesco Pharmaceuticals ETF
- PPH, VanEck Pharmaceutical ETF
- Run a portfolio x-ray to see what IXJ carries once you look through it
- Compare IXJ against any other ETF in the builder
Holdings from the most recent file iShares has published, dated 2026-10-27. Prices through 2026-10-28. How every figure here is produced. Measurements, not investment advice.
Cite this page
TickerInside, iShares Global Healthcare ETF (IXJ), holdings from the issuer's file of 2026-10-27, https://tickerinside.com/etf/ixj/, CC BY 4.0
<a href="https://tickerinside.com/etf/ixj/">TickerInside</a> (https://tickerinside.com/etf/ixj/)